CLOV CLOVER HEALTH INVESTMENTS, CORP. /DE
Hospital & Medical Service Plans · Nasdaq · SEC CIK 1801170 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
Margins
Returns
Leverage & solvency
Cash quality & payout
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-09-30 | 2026Q22026-06-30 | 2026Q12026-03-31 | 2025Q4*2025-12-31 | 2025Q32025-09-30 | 2025Q22025-06-30 | 2025Q12025-03-31 | 2024Q4*2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $759.30M | $743.17M | $749.19M | $487.71M | $496.65M | $477.62M | $462.33M | $336.96M |
| SG&A expense | $66.83M | $70.30M | $74.63M | $66.16M | $48.95M | $48.48M | $50.67M | $52.29M |
| Operating income | $6.43M | $28.00M | $27.33M | -$49.32M | -$24.38M | -$10.56M | -$1.27M | -$21.45M |
| Interest expense | — | — | — | — | — | — | — | $0 |
| Net income | $6.43M | $28.00M | $27.33M | -$49.32M | -$24.38M | -$10.58M | -$1.27M | -$22.09M |
| EBITDA | $7.04M | $28.57M | $27.85M | -$48.90M | -$23.97M | -$10.16M | -$808,000 | -$21.10M |
| EPS (basic) | 0.01 | 0.05 | 0.05 | — | -0.05 | -0.02 | 0.00 | — |
| EPS (diluted) | 0.01 | 0.05 | 0.05 | — | -0.05 | -0.02 | 0.00 | — |
| Weighted avg. shares (diluted) | 557.48M | 545.45M | 532.50M | — | 512.74M | 509.04M | 497.06M | — |
| Banking | ||||||||
| Deposits | $15.00M | $14.90M | $14.80M | $14.60M | $14.90M | $14.70M | $14.90M | $14.60M |
| Balance sheet | ||||||||
| Cash & equivalents | $268.07M | $198.84M | $173.26M | $78.30M | $190.06M | $188.65M | $155.44M | $194.54M |
| Short-term investments | $58.57M | $39.73M | $24.19M | $23.13M | $10.98M | $10.86M | $4.66M | $27.00M |
| Current assets | $535.06M | $485.45M | $448.02M | $307.86M | $330.92M | $362.94M | $331.41M | $343.12M |
| PP&E, net | $7.75M | $7.23M | $6.90M | $6.38M | $5.49M | $5.20M | $5.03M | $5.31M |
| Total assets | $753.68M | $720.33M | $697.73M | $541.01M | $559.66M | $574.99M | $583.72M | $580.74M |
| Current liabilities | $345.90M | $323.33M | $336.58M | $208.82M | $193.45M | $201.95M | $215.65M | $213.52M |
| Total liabilities | $362.81M | $344.07M | $358.30M | $232.31M | $218.73M | $230.81M | $247.64M | $239.60M |
| Shareholders' equity | $390.87M | $376.26M | $339.43M | $308.70M | $340.93M | $344.18M | $336.07M | $341.14M |
| Cash flow statement | ||||||||
| Operating cash flow | $70.38M | $25.19M | $107.89M | -$68.15M | $12.10M | $5.41M | -$16.29M | -$85.83M |
| Capital expenditure | $898,000 | $682,000 | $854,000 | $597,000 | $692,000 | $569,000 | $185,000 | $315,000 |
| Free cash flow | $69.48M | $24.51M | $107.04M | -$68.75M | $11.41M | $4.84M | -$16.48M | -$86.15M |
| Investing cash flow | -$2.88M | -$32,000 | -$5.07M | -$34.99M | -$5.42M | $35.57M | $8.93M | -$1.44M |
| Financing cash flow | $1.73M | $416,000 | -$7.86M | -$8.61M | -$5.27M | -$7.76M | -$31.74M | -$6.14M |
| Depreciation & amortization | $610,000 | $564,000 | $515,000 | $420,000 | $406,000 | $394,000 | $466,000 | $344,000 |
| Stock-based compensation | $8.02M | $8.90M | $12.27M | $24.92M | $26.11M | $26.20M | $26.44M | $29.64M |
| Share buybacks | $0 | $0 | $0 | $0 | $1,000 | $0 | $18.30M | $0 |
Free plan shows the latest 8 periods; Pro shows all 28 🔒
· Financial companies (banks, insurers, …) usually do not report gross profit or operating income; bank revenue is net revenue (net interest income + noninterest income), smaller than "gross interest income + noninterest income".
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.